GlassScriptPhysician profile
Anylou Leano
NPI 1417291170
$1,879.55
in general payments reported to CMS, 2019-2025
14 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $525 · 2023: $239 · 2024: $336 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $892.79 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Collegium Pharmaceutical, INC. | $321.51 | 2022-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $300.61 | 2021-2025 | Relistor |
| Hikma Pharmaceuticals USA | $119.33 | 2022 | |
| Nevro Corp. | $40.61 | 2022-2024 | Senza |
| Biodelivery Sciences International, INC. | $37.53 | 2021 | |
| Scilex Pharmaceuticals INC. | $31.45 | 2023-2024 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $23.09 | 2025 | |
| Impel Pharmaceuticals INC. | $22.53 | 2022 | |
| Si-Bone, INC. | $22.25 | 2023 | |
| Tonix Medicines, INC. | $19.22 | 2025 | Tonmya |
| Uswm, LLC | $16.72 | 2021 | |
| Valinor Pharma, LLC | $16.14 | 2024 | Movantik |
| Novo Nordisk INC | $15.77 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anylou Leano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.